Skip to Content

  • Search

View Additional Section Content

ECOG E5202 - A Randomized Phase III Study Comparing 5 F-U, Leucovorin and Oxaliplatin versus 5 FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers.

Clinical Trial Categories

  • Colorectal Cancer
The Rosenfeld Cancer Center at 215-481-2402


  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details